REVIEW OF ONE DECADE OF KIDNEY BIOPSIES IN TARANAKI
Samuel King1 1Taranaki Base Hospital/Te Whatu Ora, New Plymouth, New Zealand
Abstract
Aim:
Review the indication, quality, complications and histopathologic results for all kidney biopsies completed at Taranaki Base Hospital from January 2010 to December 2021
Background:
The kidney biopsy is the gold standard investigation for many kidney related illnesses. The indication for biopsy is dependent on the potential to alter clinical management for a patient. Biopsies are not without risk, ranging from minor complications such as frank haematuria in 3 to 14.5% of biopsies, to rare complications such as death at 0.2%.
Methods:
Patient data was obtained from the RenalReality database. Quality was determined based on number of glomeruli and availability of histopathologic diagnosis. Indication for biopsy, demographics, histopathology, complications and management decisions were available through RenalReality.
Results:
148 biopsies occurred over the 10 years studied. 111 completed by radiologists, 21 by nephrologists, and 16 unknown. There was no statistical difference between the quality and complications.
4% of biopsies were inadequate for histopathologic examination.
9.5% of biopsies resulted in visible hematuria, 2% resulted in serious bleeding requiring intervention. There was one death attributed to the biopsy.
Proteinuria was the most common indication for biopsy (27%) followed by AKI (24.3%), CKD (10.1%) and nephrotic syndrome (9.4%)
The most common histopathologic diagnosis was diabetic glomerulosclerosis (14.2%) followed by membranous nephropathy (12.2%), IgA nephropathy (9.4%) and focal segmental glomerulosclerosis (8.7%).
A change in clinical management post-biopsy could be determined in 52% of cases
Conclusions:
Of 148 biopsies completed at Taranaki Base Hospital over the past 10 years, 96% were of adequate quality for histopathologic diagnosis. Complication rates included serious bleeding requiring intervention in 2% of cases, and one death. There was no difference in quality or complications between clinicians.
Biography
Dr Samuel King is a BPT registrar with an interest in nephrology.
